SEARCH

Current Edition

ABBVIE

AbbVie keeps up dealmaking pace in neuroscience

Dive Brief: AbbVie announced Friday a new agreement with its longtime partner Gedeon Richter to research and develop dopamine-regulating treatments for neuropsychiatric diseases.   According …

Continue Reading →